Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?

Frédéric Velard 1 Martial Delion 1 Flora Lemaire 1 Olivier Tabary 2 Christine Guillaume 1 Françoise Le Pimpec Barthès 3 Lhousseine Touqui 4 Sophie Gangloff 1 Isabelle Sermet-Gaudelus 5, 6 Jacky Jacquot 1
1 BIOS - Biomatériaux et inflammation en site osseux - EA 4691
2 CR Saint-Antoine - Centre de Recherche Saint-Antoine
3 HEGP - Hôpital Européen Georges Pompidou [APHP]
4 Défense innée et inflammation
5 Service de Pneumologie Allergologie [CHU Necker]
6 USPC - Université Sorbonne Paris Cité
Document type :
Journal articles
Complete list of metadatas
https://hal.univ-reims.fr/hal-02014021
Contributor : Frédéric Velard <>
Submitted on : Monday, February 11, 2019 - 1:21:03 PM
Last modification on : Thursday, June 27, 2019 - 1:24:13 AM

Links full text

openaccess

Identifiers

Collections

URCA | U938 | UPMC | BIOS | CAPSANTE | SORBONNE-UNIVERSITE | SU-MEDECINE | PASTEUR

Citation

Frédéric Velard, Martial Delion, Flora Lemaire, Olivier Tabary, Christine Guillaume, et al.. Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?. European Respiratory Journal, European Respiratory Society, 2015, 45 (3), pp.845-848. ⟨10.1183/09031936.00174014⟩. ⟨hal-02014021⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

130

 

HAL-contact@univ-reims.fr